Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

With Woodcock’s Retirement, US FDA Loses A Renaissance Woman

Nov 17 2023

• By Sarah Karlin-Smith

Janet Woodcock — • Source: Getty Images

Related Content

CDER’s Woodcock Retiring? Rumors Never Go On Furlough

Oct 14 2013

Woodcock Focusing On Food Issues, Rather Than Drugs, As US FDA’s Principal Deputy Commissioner

May 20 2022

US FDA’s Woodcock Sees Clinical Trial Reform Coming, But ‘Not Wholly Optimistic’

Dec 14 2021

Woodcock Era At CDER Ends: Cavazzoni Becomes Permanent Director Of US FDA’s Drug Center

Apr 12 2021

Woodcock's Consideration of Sarepta Financial Issues Raises Eyebrows

Sep 20 2016

‘I’m Still Here’: Janet Woodcock’s Swan Song At US FDA Looking Like A Longer-Term Job

Aug 19 2022

COVID-19 Staff Shakeup: Woodcock Moves to Commissioner's Office As Marks Drops Out Of 'Warp'

May 23 2020

US FDA Regulatory Affairs Reorg To Include Inspectors Trained In Real-World Evidence, Califf Says

Oct 20 2023

Related Companies

Sarepta Therapeutics, Inc.

Additional Topics

United States FDA Regulation Leadership BioPharmaceutical

More from US FDA

More from Agency Leadership

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window